Etienne G. L.
- Country
- France
- Department
- Maladies respiratoires et Oncologie thoracique
Research Overview
- Phase I/IIa Study of Inhaled CIS-DPI as Adjunctive Therapy in Stage IV Non-Small Cell Lung Cancer Patients
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Patients With Previously Treated TROP2-Positive Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Efficacy and Safety of PF-08634404 Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 361 of 586 partner sites.
Specializations
Advanced Lung Cancer Treatment
This investigator specializes in the treatment of advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with particular focus on developing therapeutic strategies for patients with metastatic disease.
- Metastatic NSCLC Management
- SCLC Treatment Approaches
- Locally Advanced Disease Therapy
The investigator works extensively with various therapeutic modalities for both early-stage and advanced lung cancers.
Targeted Therapies
Expertise in treating lung cancers with specific genetic alterations, including EGFR mutations and RET fusion-positive tumors. Specializes in precision medicine approaches for molecular subtypes of lung cancer.
- EGFR Exon 20 Insertion Treatments
- RET Fusion-Positive NSCLC
- Molecular-Guided Therapies
Focuses on matching specific genetic alterations with targeted therapeutic approaches.
Immunotherapy Innovation
Investigates novel immunotherapy combinations and treatment strategies, including evaluation of new immune checkpoint inhibitors and their combinations with conventional therapies.
- Checkpoint Inhibitor Combinations
- Novel Immunotherapy Agents
- Multimodal Treatment Approaches
Explores innovative immunotherapy approaches for improving patient outcomes in lung cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.